DNAnexus® has built the world’s most secure, trusted cloud platform and global network for scientific collaboration and accelerated discovery. We partner with customers to tackle the world’s most exciting opportunities in human health and beyond.

NAVIFY Tumor Board is a cloud-based workflow product that securely integrates and displays relevant aggregated data into a single, holistic patient dashboard for oncology care teams to review, align and decide on the optimal treatment for the patient. NAVIFY Mutation Profiler is a Next Generation Sequencing (NGS) tertiary analysis and reporting solution that can help labs confidently, clearly and efficiently interpret the significance of mutations. NAVIFY Mutation Profiler increases lab efficiency and enables scalability by helping reduce curation time and by automating report generation.

Responsible for managing and growing a $14 million territory as well as hitting an aggressive growth goal. I sell the entire Quest Diagnostics catalog to hospitals, physician offices, academic and specialty centers. Call points are Laboratory, C-Suite, Oncology, Pathology, Neurology, Women’s health, Internal Medicine, GI, IT, Purchasing, Contracting etc. • Successfully grew territory from 78% to 97% in first 9 months• Negotiated contract extensions with 3 largest accounts securing over $8M over the next 3 years• Viewed by other reps as a Genetic Testing Specialist and speak to accounts on oncology related testing• Introduced novel Neurology, Infectious disease, Metabolic, Genetic and Microbiology tests• Increased knowledge in overall system coverage, including contract negotiating, interfacing, payer coverage, etc.• Two vacant positions blended to create this role

Responsible for promoting OncoVantage Solid Tumor Mutation/Biomarker Analysis tests, the entire Hereditary Cancer Panel offering, MSI, IHC and Blood Panel Lynch Testing to Oncologists, Pathologists, Genetic Counselors, OB/GYNs, Breast Surgeons, GI’s, Reference Labs, etc. Product Specialist for 9 local hospital and physician account executives and managers.• Introduced new and expanded panels of our QuestVantage line of hereditary cancer tests• Ranked #1 in Nation for OncoVantage testing in Q3 & Q4 2015 and Q1 2016. • Team lead on 2015 BRCA Initiative providing education and targeting strategy to AE’s and AM’s• Robust training in Biomarker Analysis, Genetic testing and Targeted Therapies• Integrity Selling Sales Training

Created/maintained the website, managed memberships and marketing along with all other aspects of owning a gym.

I introduced the DNA Insight™ line of genetic tests to Oncologists, OB/GYNs, Genetic Counselors, Breast Surgeons, Gastroenterologists, Endocrinologists, Pain Specialists and Nutritionists. Testing categories included Cancer Risk (BRCA & Colorectal), Carrier Screening, Cardiac Health, Pain Medication Response (Pharmacogenomics) & Weight Management (Nutrigenomics). Was part of a mass lay-off in July.

I sold ResponseDX, a line of molecular diagnostic tests that predict a patient’s responsiveness to a particular treatment by extracting and analyzing genetic information derived from tumor cells. Biomarkers included Lung, Breast, Melanoma, Colon, Gastric, Thyroid, Brain and Tissue of Origin. My call points were Oncologists, Pathologists, Reference Labs, Genetic Counselors and C-Suite Executives. • Introduced New Biomarkers, Tissue Of Origin test, Digital Annotation Program, TC/PC and New Branding• Ranked #1 in the nation for Tissue Of Origin Test (TOO)- Only winner of TOO sales challenge• Closed over 40 new customers and have grown or maintained all current business• Took over vacant, five state territoryMy goal was to help Oncologists with therapeutic treatment decisions for patients with non-small cell lung cancer (NSCLC) EGFR, ALK(FISH & RT PCR),ROS-1(FISH), BRAF, RET(FISH) MET(FISH) and many more. Colorectal, Gastric, Melanoma, Breast, Brain & Liver Cancer Panels available as well. Our Tech-Only Services can be easily integrated to your existing practice. We will perform the FISH testing and deliver the results (TC), you perform the professional consulting (PC) services and bill appropriately for them. We use the most advanced imaging platform available, BioView® SoloWeb. By integrating leading-edge technology with our secure customer portal, we offer you the ability optimize your workflow, access cases remotely via standard web browsers, and review, analyze and report using the most intuitive interface available in the market. Response Genetics, Inc. (“RGI”) (NASDAQ:RGDX) is engaged in the research and development of pharmacogenomic cancer diagnostic tests based on its proprietary and patented technologies which enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin embedded specimens.

I sold the Pronto & Pronto 7 for non-invasive and quick spot-checking of total hemoglobin (SpHb®), SpO2, pulse rate, and perfusion index to the Lab, OB/GYN, Point of Care Coordinators, Pediatrics, Primary Care Physicians, Internal Medicine, Pulmonologists, Office Managers and Purchasing in IHN’s, Hospitals and Clinics.

•Regional Account Manager, Roche Diagnostics, Minnesota/South Dakota 12/06-1/12•Sell Coaguchek POC PT/INR product line and Chemstrip Urinalysis/Micral product line to multiple call points•Call mostly on Lab, Primary Care Physicians, Internal Medicine, Point of Care Coordinators, Cardiologists and office managers in IHN’s, hospitals and clinics•Currently experiencing 19% YOY growth in 2011•2010 accomplished sales of $1.6 million at 101% of goal•2009 accomplished 103% of goal with 17% growth•2008 finished 1st in region of 9, 11th out of 72 at 118% of goal with 32% growth and earned “Platinum” status•2007 accomplished 101% of goal after taking over territory during devastating product recall•Launched 3 new products and 2 new services to market•Launched new concept to assist Health Care Providers in delivering better patient care•Completed and currently utilizing Miller/Heiman Foundation series Conceptual and Strategic Selling sales training•Certified with Reptrax, Status Blue and Vendormate•HIPAA Certified

First line customer contact in all motorcycle and retail sales. • Demo ride tour leader• Demo Model at Donnie Smith and other National Motorcycle Shows